XENE Competitors & Alternatives
Compare Xenon Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
XENE
Main Stock$66.50
Tradestie Score
56
Market Cap
$3.02B
Revenue Growth
-1.0%
Analyst Upside
+21.1%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$240.71
|
$8.30B | 2469.1 | 65 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$81.66
|
$6.68B | - | 64 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$105.77
|
$6.64B | - | 62 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$136.35
|
$6.38B | - | 56 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$25.92
|
$6.03B | - | 52 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$51.63
|
$6.02B | - | 53 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 59 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$226.37
|
$5.92B | - | 60 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$54.97
|
$5.80B | 20.0 | 61 | Compare |
More XENE Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry